In this week’s episode of “Podnosis,” we’re diving deep into the current landscape of clinical trials in the U.S.

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

A recent rulemaking regarding patient care decision support tools is an important step forward in ensuring safety and equity ...

Amid tightening EU regulations, a growing emphasis on digitalisation and artificial intelligence (AI), and complex questions ...

Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

USC professor Berislav Zlokovic is on leave after whistleblowers cast doubt on his published work and derailed trials for an ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

The clinical research industry has accelerated its development in recent years, especially in early-phase trials but it’s ...

The Lupus Foundation of America (LFA) is proud to honor two exceptional lupus researchers at the 2024 Evelyn V. Hess ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Amber Hill spent 14 years as a medical researcher. She didn't mind the work, but there was one thing she consistently hated: ...